Enhanced stress responsivity of tourette syndrome patients undergoing lumbar puncture

Biological Psychiatry

Volumn 36, Issue 1, 1994, Pages 35-43

  Chappell, Philip ^a   Riddle, Mark ^a   Anderson, George ^a   Scahill, Larry ^a   Hardin, Maureen ^a   Walker, David ^a   Cohen, Donald ^a   Leckman, James ^a  

^a YALE UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

adrenocorticotropin; cortisol; lumber puncture; norepinephrine; stress; Tourette syndrome

Indexed keywords

CORTICOTROPIN; HYDROCORTISONE; NORADRENALIN;

ADULT; ANXIETY; ARTICLE; CLINICAL ARTICLE; CONTROLLED STUDY; FEMALE; GILLES DE LA TOURETTE SYNDROME; HUMAN; MALE; PRIORITY JOURNAL; SELF CONCEPT; STRESS;

ADULT; ANALYSIS OF VARIANCE; ANXIETY; CORTICOTROPIN; DOPAMINE; EPINEPHRINE; FEMALE; HUMAN; HYDROCORTISONE; MALE; NOREPINEPHRINE; PILOT PROJECTS; PSYCHIATRIC STATUS RATING SCALES; SPINAL PUNCTURE; STRESS; SUPPORT, U.S. GOV'T, P.H.S.; TOURETTE SYNDROME;

EID: 0028366055     PISSN: 00063223     EISSN: None     Source Type: Journal    
DOI: 10.1016/0006-3223(94)90060-4     Document Type: Article

References (45)

1. Liquid chromatographic determination of urinary catecholamines after one-step alumina extraction
2. Brain monoamines and amino acids in Gilles de la Tourette's syndrome: A preliminary study of subcortical regions (Letter)
3. Reduced excretion of MHPG in Tourette syndrome
4. Urinary amines in adults with Tourette's syndrome
5. A survey of Tourette syndrome patients and their families: The 1987 Ohio Tourette Survey
6. Neurobiological effects of lumbar puncture stress in psychiatric patients and healthy volunteers
7. The natural history of Tourette syndrome
8. Biogenic amine metabolism in Tourette syndrome
9. Biochemical and genetic studies of Tourette's syndrome: implications for treatment and future research
10. Neuroendocrine and behavioral effects of naloxone in Tourette syndrome
11. Comorbidity, Tourette syndrome, and anxiety disorders
12. Clonidine in Tourette's syndrome
13. Central biogenic amine metabolism in children with the syndrome of chronic multiple tics of Gilles de la Tourette
14. Clonidine ameliorates Gilles de la Tourette syndrome
15. Tourette syndrome: extending basic research to clinical care
16. Stress, feedback, and facilitation in the hypothalamo-pituitary adrenal axis
17. The Yale-Brown Obsessive Compulsive Scale: I. Development, use, and reliability
18. Basal ganglia peptidergic staining in Tourette syndrome: a follow-up study
19. The assessment of anxiety states by rating
20. A rating scale for depression
21. Catecholamine metabolism in Gilles de la Tourette's syndrome
22. Growth hormone response to clonidine in children ages 4–17: Tourette syndrome vs. children with short stature
23. The pathogenesis of Gilles de la Tourette's syndrome: A review of data and hypothesis
24. Short and long term treatment of Tourette's syndrome with clonidine: A clinical perspective
25. Rebound phenomena in Tourette's syndrome after abrupt withdrawal of clonidine
26. Tic disorders
27. Elevated CSF Dynorphin A[1–8] in Tourette's syndrome
28. The Yale Global Tic Severity Scale: Initial testing of a clinician-related scale of tic severity
29. Clonidine treatment of Gilles de la Tourette's syndrome
30. Premonitory urges in Tourette's syndrome
31. Tics and Tourette's disorder: a2- to 7-year follow-up of 54 obsessive-compulsive children
32. Exacerbation of Gilles de la Tourette's syndrome associated with thermal stress: a family study
33. Clinical and medication outcome after short-term alprazolam and behavioral group treatment in panic disorder
34. The genetics of Gilles de la Tourette's syndrome
35. Reduced basal ganglia volumes in Tourette's syndrome using 3-dimensional reconstruction techniques from magnetic resonance images
36. Catecholaminergic Modulation of Corticotropin-Releasing Factor and Adrenocorticotropin Secretion
37. Is buspirone effective for panic disorder?
38. Environmental factors and related fluctuations of symptoms in Tourette's disorder
39. 2-adrenoreceptorsand plasmanorephrine of children with Tourette syndrome
40. Dopaminergic dysfunction in Tourette syndrome
41. Gilles de la Tourette: A 20-month study of the effects of stressful life events and haloperidol on symptom frequency